Results for: Immune System

josep bassaganya-riera announcing 10 million dollar investment in his biotherapeutics spinoff company

September 29, 2017

Lab Director Raises $10 Million to Launch Private Development of Therapeutics for Autoimmune Disease

Biocomplexity Institute Lab Director Josep Bassaganya-Riera announced a successful round of Series A funding for his privately established biotherapeutics company. Landos Biopharma Inc. will develop treatments for Crohn’s disease and ulcerative colitis that could bring relief to the approximately 1.6 million American and 4 million global sufferers of IBD. 

June 15, 2017

Researchers Uncover New Immunometabolic Target for Inflammatory Bowel Disease Treatments

Researchers at the Biocomplexity Institute of Virginia Tech have discovered a new therapeutic target for inflammatory bowel disease, and it’s right inside our immune cells: a gene known as NLRX1.

April 21, 2017

Research Shines Positive Light on Harmful Bacteria

Researchers at the Biocomplexity Institute of Virginia Tech are exploring why H. pylori bacteria are harmful to some people, while providing health benefits to others.

March 07, 2017

Molecular Alarm System Ensures Your Body’s First Response to an Attack Will be a Healthy One

If it’s not shut off at the appropriate time, the body's innate immune response can begin to spike at dangerous levels — a condition that’s been closely linked to heart disease, allergies, obesity, degenerative brain diseases, and cancer. Biocomplexity Institute researchers have discovered a molecular mechanism that keeps this reaction within healthy limits.

February 09, 2017

New Mathematical Model Sheds Light on HIV-HPV Co-Infection

In addition to being difficult to treat, HIV leaves the body open to many other co-infections, including HPV, the most common sexually transmitted infection in the United States. Biocomplexity Institute researchers have developed a first-of-its-kind computational model to study how these two diseases impact each other's treatment and persistence.

November 06, 2015

Researchers Test ‘Smart’ Simulations to Analyze Unknown Variables in Immune Response

BLACKSBURG, Va., Nov. 6, 2015 – Technology to predict how our bodies will manage chronic diseases such as Crohn’s disease and inflammatory bowel disease promises to accelerate the discovery of new treatments, identify leads for further study, and occasionally uncover hidden knowledge about how our immune system operates.